Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Case Comprehensive Cancer Center
Massachusetts General Hospital
New Approaches to Neuroblastoma Therapy Consortium
City of Hope Medical Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Albert Einstein College of Medicine
OHSU Knight Cancer Institute
New Approaches to Neuroblastoma Therapy Consortium
Children's Hospital Los Angeles
New Approaches to Neuroblastoma Therapy Consortium
Barbara Ann Karmanos Cancer Institute
St. Anna Kinderkrebsforschung
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sarcoma Alliance for Research through Collaboration
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
City of Hope Medical Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
NYU Langone Health
Memorial Sloan Kettering Cancer Center
NYU Langone Health
Indiana University
University of California, San Francisco
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Duke University
University of Kentucky
Barbara Ann Karmanos Cancer Institute
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Southampton
St. Jude Children's Research Hospital
NYU Langone Health
New Approaches to Neuroblastoma Therapy Consortium
Children's Hospital Los Angeles
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center